Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1994-11-3
|
| pubmed:abstractText |
Despite careful preoperative staging, approximately 50% of patients who undergo radical prostatectomy for clinical stage A2 (T1b-c) and B (T2) prostate cancer are found to have pathologic stage C (T3-4) or D (N1) disease. This study investigates whether preoperative serum prostate specific antigen (PSA) and Gleason grade predict pathologic stage among patients with clinically organ confined prostate cancer.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0360-3016
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
30
|
| pubmed:volume |
30
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
317-22
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:7523342-Adenocarcinoma,
pubmed-meshheading:7523342-Combined Modality Therapy,
pubmed-meshheading:7523342-Humans,
pubmed-meshheading:7523342-Male,
pubmed-meshheading:7523342-Neoplasm Staging,
pubmed-meshheading:7523342-Prostate-Specific Antigen,
pubmed-meshheading:7523342-Prostatectomy,
pubmed-meshheading:7523342-Prostatic Neoplasms,
pubmed-meshheading:7523342-Retrospective Studies
|
| pubmed:year |
1994
|
| pubmed:articleTitle |
Preoperative serum prostate-specific antigen and Gleason grade as predictors of pathologic stage in clinically organ confined prostate cancer: implications for the choice of primary treatment.
|
| pubmed:affiliation |
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510.
|
| pubmed:publicationType |
Journal Article
|